Clean Yield Group maintained its stake in shares of Cigna Corporation (NYSE:CI) during the second quarter, according to its most recent disclosure with the SEC. The firm owned 1,647 shares of the health services provider’s stock at the end of the second quarter. Clean Yield Group’s holdings in Cigna Corporation were worth $286,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. American Beacon Advisors Inc. purchased a new position in shares of Cigna Corporation during the first quarter worth $102,000. Baystate Wealth Management LLC boosted its position in shares of Cigna Corporation by 436.1% in the first quarter. Baystate Wealth Management LLC now owns 772 shares of the health services provider’s stock worth $116,000 after buying an additional 628 shares in the last quarter. Founders Capital Management bought a new position in shares of Cigna Corporation during the first quarter worth approximately $117,000. Mckinley Capital Management LLC Delaware bought a new position in shares of Cigna Corporation during the first quarter worth approximately $122,000. Finally, Guardian Life Insurance Co. of America boosted its position in shares of Cigna Corporation by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock worth $145,000 after buying an additional 7 shares in the last quarter. 86.87% of the stock is owned by institutional investors and hedge funds.
Shares of Cigna Corporation (NYSE CI) opened at 172.10 on Wednesday. Cigna Corporation has a 52 week low of $115.03 and a 52 week high of $174.46. The firm has a 50-day moving average of $168.26 and a 200 day moving average of $155.43. The firm has a market capitalization of $44.06 billion, a price-to-earnings ratio of 22.98 and a beta of 0.46.
Cigna Corporation (NYSE:CI) last issued its quarterly earnings data on Friday, May 5th. The health services provider reported $2.77 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.44 by $0.33. The business had revenue of $10.39 billion for the quarter, compared to the consensus estimate of $10.11 billion. Cigna Corporation had a net margin of 6.53% and a return on equity of 16.07%. The company’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.46 EPS. On average, equities analysts predict that Cigna Corporation will post $9.79 earnings per share for the current fiscal year.
WARNING: “Clean Yield Group Has $286,000 Stake in Cigna Corporation (CI)” was first posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this news story on another website, it was illegally stolen and reposted in violation of US and international copyright laws. The legal version of this news story can be accessed at https://stocknewstimes.com/2017/07/19/clean-yield-group-has-286000-stake-in-cigna-corporation-ci.html.
CI has been the topic of several recent analyst reports. UBS AG reiterated a “buy” rating and issued a $186.00 price target (up previously from $181.00) on shares of Cigna Corporation in a research note on Monday, June 5th. Bank of America Corporation boosted their price objective on Cigna Corporation from $193.00 to $198.00 and gave the company a “buy” rating in a report on Friday, June 23rd. Jefferies Group LLC reissued a “buy” rating and issued a $183.00 price objective on shares of Cigna Corporation in a report on Thursday, June 8th. Zacks Investment Research lowered Cigna Corporation from a “hold” rating to a “sell” rating in a report on Wednesday, April 5th. Finally, Deutsche Bank AG boosted their price objective on Cigna Corporation from $172.00 to $175.00 and gave the company a “buy” rating in a report on Wednesday, May 10th. Two equities research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $176.33.
In other news, insider Michael W. Triplett sold 1,439 shares of the company’s stock in a transaction dated Wednesday, June 14th. The shares were sold at an average price of $166.89, for a total value of $240,154.71. Following the sale, the insider now directly owns 26,199 shares of the company’s stock, valued at approximately $4,372,351.11. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO David Cordani sold 153,168 shares of the company’s stock in a transaction dated Monday, June 19th. The stock was sold at an average price of $170.20, for a total transaction of $26,069,193.60. Following the completion of the sale, the chief executive officer now directly owns 421,162 shares in the company, valued at $71,681,772.40. The disclosure for this sale can be found here. Over the last three months, insiders have sold 195,201 shares of company stock worth $32,862,614. Insiders own 1.30% of the company’s stock.
Cigna Corporation Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
